York Capital Management Global Advisors, LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is 0.18 and the average weighting 1.1%.

Quarter-by-quarter ownership
York Capital Management Global Advisors, LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q4 2020$35,749,000
-77.8%
302,675
-79.2%
3.52%
-60.9%
Q3 2020$161,361,000
+17.2%
1,451,870
+7.7%
9.00%
-1.0%
Q2 2020$137,728,000
+49.9%
1,347,897
+58.3%
9.09%
+66.2%
Q1 2020$91,899,000
-28.4%
851,474
-22.7%
5.47%
-26.1%
Q4 2019$128,270,000
+6.6%
1,102,163
+4.8%
7.40%
+32.6%
Q3 2019$120,358,000
+11.9%
1,051,438
-6.8%
5.58%
+27.9%
Q2 2019$107,567,000
+18.9%
1,128,717
+13.9%
4.36%
+7.7%
Q1 2019$90,450,000
-1.4%
991,233
-17.9%
4.05%
-27.3%
Q4 2018$91,690,000
-1.8%
1,207,869
+3.4%
5.57%
+88.6%
Q3 2018$93,411,000
+13.6%
1,167,643
+41.1%
2.95%
+47.5%
Q2 2018$82,219,000
+197.1%
827,738
+142.3%
2.00%
+221.9%
Q1 2018$27,671,000
+118.4%
341,616
+112.4%
0.62%
+102.6%
Q4 2017$12,670,000
+353.1%
160,847
+430.9%
0.31%
+403.3%
Q3 2017$2,796,00030,2980.06%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2020
NameSharesValueWeighting ↓
Kite Lake Capital Management (UK) LLP 207,382$24,135,00076.46%
Maso Capital Partners Ltd 539,597$62,798,00020.20%
York Capital Management Global Advisors, LLC 1,102,163$128,270,0007.40%
HHLR ADVISORS, LTD. 2,751,200$320,185,0003.99%
Dalton Investments, Inc. 15,551$1,810,0001.14%
Athos Capital Ltd 8,290$965,0000.96%
Myriad Asset Management Ltd. 67,019$7,799,0000.94%
Temasek Holdings (Private) Ltd 990,000$115,216,0000.75%
OXFORD ASSET MANAGEMENT LLP 211,646$24,631,0000.68%
AGF Investments America Inc. 12,230$1,423,0000.47%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders